TITLE

Vaccines Get a Boost

PUB. DATE
March 2010
SOURCE
Pharmaceutical Representative;Mar2010, Vol. 40 Issue 3, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the Bill and Melinda Gates Foundation has pledged to donate 10 billion dollars over the next ten years to help global research and development in the delivery of vaccines in poor and developing countries.
ACCESSION #
48316570

 

Related Articles

  • The global value of vaccination. McWilliams, Pauline // PharmacoEconomics & Outcomes News;6/25/2011, Issue 631, p3 

    The article discusses three studies on the Decade of Vaccines as pledges during the conference held by the Global Alliance for Vaccines and Immunisation (GAVI) in London, England on June 13, 2011 reached 4.3 billion U.S. dollars. It notes that the economics of the 10-year initiative is based on...

  • Gates Foundation seeks innovative concepts for animal vaccines.  // Veterinary Record: Journal of the British Veterinary Association;11/15/2014, Vol. 175 Issue 19, p468 

    The article focuses on the move of the Bill & Melinda Gates Foundation to seek applications for funding from research projects with an aim to develop new animal vaccines.

  • Vaccine funds will save lives. Willyard, Cassandra // Nature Medicine;Mar2010, Vol. 16 Issue 3, p243 

    The article reports on the intention of Gates Foundation to donate 10 billion dollars to fund vaccine research, development and delivery in the U.S. in 2020.

  • GSK to go cold turkey and quit the fridge.  // TCE: The Chemical Engineer;Dec2013/Jan2014, Issue 870/871, p8 

    The article reports on a joint project between healthcare company GlaxoSmithKline (GSK) and nonprofit Bill & Melinda Gates Foundation that aims to bring malaria and HIV drugs to those living in the hottest and poorest regions, by making vaccines more resistant to heat.

  • It's All in the DELIVERY. Dove, Alan // Drug Discovery & Development;Jun2007, Vol. 10 Issue 6, p20 

    The article discusses the proposed plan by the Bill and Melinda Gates Foundation to develop an aerosolized form of Bacillus Calmette-Guerin (BCG) in Seattle, Washington. They will challenge the researchers to develop inhaled formulations of the most common childhood vaccines to address the...

  • International AIDS Vaccine Initiative Encourages Nations Worldwide to Support Advance Market Commitments to Combat Neglected Diseases.  // Ascribe Newswire: Medicine;2/9/2007, p4 

    The article reports that the International AIDS Vaccine Initiative has acknowledged the governments of Canada, Italy, Norway, Russia, and Great Britain as well as the Bill & Melinda Gates Foundation for their leadership and generosity in establishing a pilot Advance Market Commitment (AMC)...

  • The one to watch in 2008. Byrnes, Sholto // New Statesman;1/7/2008, Vol. 137 Issue 4878, p24 

    In this article the author examines efforts to combat malaria undertaken by Pedro Alonso, a medical researcher working in Mozambique. Alonso may be close to developing a vaccine against the disease which has a significant impact on the health of children, particularly in Africa. Alonso's...

  • Pharmacists' roles in a 'Decade of Vaccines'. Foster, Stephan L. // Pharmacy Today;Aug2011, Vol. 17 Issue 8, p50 

    The author reflects on the roles of pharmacists in an era of many new vaccines. He highlights the commitment of the Bill and Melinda Gates Foundation to research, development and the delivery of vaccines to poorest countries in the world. He promotes the need to understand the broader...

  • Around the world in a month.  // Nature Biotechnology;Dec2013, Vol. 31 Issue 12, p1067 

    The article offers world news briefs related to drug trade as of December 2013 which includes the Brazil's laboratory partnering with Bill & Melinda Gates Foundation for rubella vaccine development, Beta Renewables SpA plant opening in Italy, and Spain's production of genetically modified corn.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics